Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control

Saved in:

Bibliographic Details
Published in	Ophthalmology (Rochester, Minn.) Vol. 123; no. 9; pp. 2047 - 2050
Main Authors	Nguyen, Diem-Trang, MD, Houillier, Caroline, MD, Choquet, Sylvain, MD, PhD, Cassoux, Nathalie, MD, PhD, Soussain, Carole, MD, Le Cossec, Chloé, MD, Legarf-Tavernier, Magali, MD, PhD, Costopoulos, Myrto, PharmD, LeHoang, Phuc, MD, PhD, Bodaghi, Bahram, MD, PhD, Omuro, Antonio, MD, Hoang-Xuan, Khe, MD, PhD, Touitou, Valérie, MD, PhD
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.09.2016
Subjects	Aged Aged, 80 and over Antimetabolites, Antineoplastic - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Central Nervous System Neoplasms - drug therapy Central Nervous System Neoplasms - pathology Cerebellum - diagnostic imaging Cytarabine - administration & dosage Dacarbazine - administration & dosage Dacarbazine - analogs & derivatives Eye Neoplasms - drug therapy Eye Neoplasms - pathology Female Humans Lymphoma - drug therapy Lymphoma - pathology Magnetic Resonance Imaging Male Methotrexate - therapeutic use Middle Aged Ophthalmology Procarbazine - administration & dosage Survival Analysis Vincristine - administration & dosage
Online Access	Get full text

Loading…

More Information
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23
ISSN:	0161-6420 1549-4713
DOI:	10.1016/j.ophtha.2016.03.043